ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Warszawa, Mazowieckie, POL:

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...

Active, not recruiting
Breast Cancer Stage II
Breast Cancer Stage III
Drug: doxorubicin/cyclophosphamide
Drug: Docetaxel / cyclophosphamide

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Warsaw, Poland and 72 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

Warszawa, Mazowieckie, Poland and 324 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 147 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Vinorelbine
Drug: Eribulin

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 166 other locations

Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy a...

Active, not recruiting
HER2-Positive Primary Breast Cancer
Residual Invasive Breast Cancer
Drug: DS-8201a
Drug: T-DM1

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Warsaw, Poland and 482 other locations

to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk for disease recurrence...

Enrolling
Breast Cancer, Early Breast Cancer
Drug: Anastrozole
Drug: Exemestane

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 692 other locations

in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...

Enrolling
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Datopotamab deruxtecan

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Warszawa, Poland and 46 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Nab-Paclitaxel
Drug: Trastuzumab deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Warszawa, Poland and 293 other locations

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...

Active, not recruiting
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Trilaciclib
Drug: Placebo

Phase 3

G1 Therapeutics

Warszawa, Poland and 70 other locations

This study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast...

Enrolling
HER2 Positive Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 3

Seagen
Seagen

Warszawa, Other, Poland and 290 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems